BASE10 Collaborates with DNA Link to Support Authorization of COVID-19 IgG Antibody Test at the Point of Care
Shots:
- The companies collaborated to evaluate the usability of DNA Link's AccuFind COVID-19 IgG antibody test in a healthcare setting
- The study intends to expand access to antibody testing outside of laboratory settings
- The companies plan to launch the study in Dec’2020
Ref: PRNewswire | Image: Base 10 genetics
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com
